Skip to main content
. 2018 Jul-Sep;10(3):289–293. doi: 10.4103/JLP.JLP_176_17

Table 3.

The comparative evaluation of meropenem susceptibility results by the two guidelines (n=501)

graphic file with name JLP-10-289-g003.jpg